Adage Capital Partners GP L.L.C. Decreases Stake in Aflac Incorporated (NYSE:AFL)

Adage Capital Partners GP L.L.C. lessened its stake in shares of Aflac Incorporated (NYSE:AFLFree Report) by 3.8% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 262,474 shares of the financial services provider’s stock after selling 10,400 shares during the quarter. Adage Capital Partners GP L.L.C.’s holdings in Aflac were worth $20,145,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in AFL. Norges Bank purchased a new position in Aflac during the 4th quarter valued at about $175,416,000. Invesco Ltd. grew its holdings in Aflac by 62.4% during the 1st quarter. Invesco Ltd. now owns 4,936,608 shares of the financial services provider’s stock valued at $317,865,000 after buying an additional 1,897,212 shares in the last quarter. Morgan Stanley grew its holdings in Aflac by 22.9% during the 4th quarter. Morgan Stanley now owns 8,812,956 shares of the financial services provider’s stock valued at $634,004,000 after buying an additional 1,640,984 shares in the last quarter. Point72 Asset Management L.P. purchased a new position in Aflac during the 4th quarter valued at about $72,249,000. Finally, Barclays PLC grew its holdings in Aflac by 67.3% during the 2nd quarter. Barclays PLC now owns 1,712,568 shares of the financial services provider’s stock valued at $119,539,000 after buying an additional 689,173 shares in the last quarter. Hedge funds and other institutional investors own 66.75% of the company’s stock.

Insiders Place Their Bets

In other Aflac news, Director Arthur Reginald Collins sold 3,000 shares of the stock in a transaction on Thursday, February 22nd. The stock was sold at an average price of $79.73, for a total value of $239,190.00. Following the completion of the transaction, the director now owns 5,592 shares in the company, valued at $445,850.16. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other news, Director Masatoshi Koide sold 30,493 shares of the firm’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $79.91, for a total transaction of $2,436,695.63. Following the completion of the transaction, the director now directly owns 86,090 shares in the company, valued at $6,879,451.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Arthur Reginald Collins sold 3,000 shares of the firm’s stock in a transaction on Thursday, February 22nd. The shares were sold at an average price of $79.73, for a total value of $239,190.00. Following the transaction, the director now owns 5,592 shares of the company’s stock, valued at $445,850.16. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.

Aflac Stock Performance

Shares of AFL stock opened at $82.29 on Friday. The stock has a fifty day moving average of $81.27 and a 200 day moving average of $79.78. Aflac Incorporated has a 52 week low of $60.20 and a 52 week high of $86.20. The firm has a market capitalization of $47.48 billion, a price-to-earnings ratio of 10.62, a PEG ratio of 2.21 and a beta of 0.91. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.33.

Aflac (NYSE:AFLGet Free Report) last posted its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.25 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.22). The firm had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $4.44 billion. Aflac had a return on equity of 17.59% and a net margin of 24.92%. During the same quarter last year, the company posted $1.29 EPS. As a group, research analysts expect that Aflac Incorporated will post 6.41 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on AFL. Wells Fargo & Company boosted their price objective on Aflac from $82.00 to $83.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 6th. Morgan Stanley cut their price objective on Aflac from $85.00 to $80.00 and set an “equal weight” rating for the company in a report on Friday, March 1st. Evercore ISI lowered Aflac from an “in-line” rating to an “underperform” rating and boosted their price objective for the stock from $76.00 to $78.00 in a report on Thursday, January 4th. UBS Group boosted their price objective on Aflac from $80.00 to $84.00 and gave the stock a “neutral” rating in a report on Wednesday, January 10th. Finally, Raymond James boosted their price objective on Aflac from $83.00 to $88.00 and gave the stock an “outperform” rating in a report on Friday, February 2nd. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $80.36.

Read Our Latest Report on Aflac

Aflac Profile

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Featured Stories

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFLFree Report).

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.